(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why ...

Neuropathic pain, a chronic condition resulting from nervous system lesions or diseases, remains a formidable clinical challenge due to its complex and ...

The Neuropathy Action Foundation (NAF), a non-profit organization dedicated to ensuring neuropathy patients have access to the treatments necessary to improve their quality of life, today released a ...

A study published in Biomedicines found an association between cannabis use and sustained pain reduction in a patient ...

A new, inexpensive urine test that measures two sugar alcohols, sorbitol and xylitol, is making it easier, faster, and far ...

More than 20 million Americans are affected by peripheral neuropathy – often struggling to find real, lasting relief. Many people put off treatment, ...

Neuropathy used to be considered permanent and untreatable. Josiah Fitzsimmons, DC, Founder of VERO Neuropathy, says that’s ...

Peripheral neuropathy pain can be excruciating and life-altering. What many patients don’t realize is that their mysterious nerve pain may actually be connected to an underlying Lyme disease infection ...